Prostate cancer Board decisions

The Veteran's prostate cancer was not incurred in or aggravated by service, and there is no evidence of herbicide exposure. The claim for service connection is denied.

The Veteran's appeal was dismissed due to their death, and the Board has no jurisdiction to adjudicate the merits of this appeal.

The Veteran's claims for increased ratings for service-connected prostate cancer, erectile dysfunction, and diabetes mellitus were denied. The Veteran was currently rated at 20 percent for each condition.

The Board has remanded the claims for service connection due to insufficient evidence regarding the Veteran's exposure to herbicide agents in Vietnam. The AOJ is instructed to attempt to obtain additional evidence, including SPRs and any other relevant records, to determine if the Veteran’s unit participated in missions to Vietnam.

The Veteran's claims for service connection for erectile dysfunction, increased rating for PTSD prior to March 28, 2016, and entitlement to TDIU are being remanded due to the addition of relevant VA treatment records that have not been reviewed by the AOJ.

The Veteran's prostate cancer and diabetes mellitus are granted as service connected due to presumed exposure to herbicides during his time at the Korat and U-Tapao Royal Thai Air Force bases.

The Board granted service connection for prostate cancer on a presumptive basis due to exposure to herbicide agents at U-Tapao Royal Thai Navy Airfield.

The Board has remanded the Veteran's claims for service connection due to incomplete development regarding exposure to non-ionizing radiation and a need for an addendum advisory opinion from the Under Secretary of Health.

The Veteran's prostate cancer residuals are rated at 40 percent, effective September 1, 2017. Service connection for PTSD and major depressive disorder is denied.

The Veteran's service-connected erectile dysfunction and prostate cancer have been granted, with a 40% rating from September 1, 2013 to November 19, 2014, and a 60% rating beginning November 19, 2014. The Veteran has also been granted entitlement to a total disability rating based on individual employability due to service-connected disabilities (TDIU).

The Board has denied the Veteran's request to restore a 100% rating for prostate cancer residuals, finding that the reduction from 100% to 40% was proper based on evidence showing no active disease and current urinary leakage requiring absorbent materials changed 2-4 times per day.

The Board has determined that the Veteran served in Vietnam and was exposed to herbicides, including Agent Orange. Therefore, prostate cancer is presumed to be service-connected.

The Veteran's claims for service connection for diabetes mellitus, type II and prostate cancer have been granted due to new evidence showing exposure to herbicide agents during service in Thailand. The conditions are presumed related to this exposure.

The Board dismissed the appeal for service connection due to the appellant's death.

The Veteran's death was not caused by any service-connected disability, and there is no evidence of herbicide agent exposure during his military service. Therefore, the claim for service connection for the cause of the Veteran’s death is denied.

The Board has dismissed the appeals for service connection of prostate cancer, hypertension, and diabetes mellitus type II due to the death of the Veteran.

The Board has remanded the cases for further development and examination, as records are missing or incomplete. The Veteran's sleep apnea and prostate cancer claims will be reconsidered in light of any new evidence.

The Board granted a 60 percent rating for prostate cancer residuals from March 30, 2017. Service connection was granted for hypertension as secondary to diabetes and denied for sleep apnea.

The Veteran's claim for service connection for an acquired psychiatric disability, other than PTSD, prostate cancer, erectile dysfunction, benign prostatic hypertrophy and prostatitis, urinary tract infection, urine retention, bladder incontinence, nocturia, obesity, cataracts, and fatigue was denied. The Board found that the evidence did not support a finding of service connection for any of these conditions.

The Board has decided to remand the claims for diabetes mellitus, prostate cancer, thyroid cancer, and hepatitis C due to incomplete records and need for medical opinions.